Comparison of Apnea-Hypopnea Index in Patients With or Without Preventive Oxygen Therapy After Bariatric Surgery (OXYBAR)

July 17, 2025 updated by: Rijnstate Hospital

Comparison of Apnea-Hypopnea Index, in Patients With Potentially Undiagnosed Obstructive Sleep Apnea, Treated With or Without Preventive Oxygen Therapy, During the First Night After Bariatric Surgery

The best perioperative strategy for obstructive sleep apnea (OSA) in bariatric surgery remains unclear. A strategy is to monitor patients and administer preventive oxygen therapy during the first postoperative night. However it is unknown what if preventive oxygen therapy is necessary.

The goal of this trial is to compare the Apnea-Hypopnea Index (AHI) in participants with or without preventive oxygen therapy.

Methods:

Participants are patients who underwent bariatric surgery without treated OSA and will be will be randomized into arm A or arm B:

Arm A: First postoperative night in the hospital with preventive oxygen therapy (standard care), Arm B: First postoperative night in hospital without preventive oxygen therapy (intervention).

Study Overview

Detailed Description

Rationale: The prevalence of obstructive sleep apnea (OSA) in the bariatric surgery population is high and mostly undiagnosed. The best perioperative strategy to manage sleep apnea in bariatric patients remains unclear. A recent study found that monitoring patients with pulsoximetry and giving them preventive oxygen therapy during the first postoperative night is safe and cost effective. In a population with patients with OSA but without obesity, no significant difference in apnea hypopnea index (AHI) was found between patients with and without oxygen therapy during the first postoperative night. The question was raised if preventive oxygen therapy during the first postoperative night after bariatric surgery is needed.

Objective: The primary objective of this study is to compare AHI in patients with potentially undiagnosed OSA, treated with or without preventive oxygen therapy, during the first night after bariatric surgery. The secondary objective of this study is to compare sleep architecture in these patients

Study design: This is a randomized controlled non-inferiority trial consisting of two arms; Arm A: First postoperative night in the hospital with preventive oxygen therapy (standard care), Arm B: First postoperative night in hospital without preventive oxygen therapy (intervention).

Study population: Patients scheduled for primary bariatric surgery without treated OSA Intervention: During the first postoperative night at the hospital patients in intervention arm B will not receive preventive oxygen therapy.

Main study parameters/endpoints: Primary endpoint is AHI and secondary endpoints are 30 days complications rate, nursing intervention rate and parameters for sleep architecture and sleep related breathing, score of the Epworth Sleepiness Scale (ESS) and STOP BANG.

Study Type

Interventional

Enrollment (Actual)

153

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Undergo primary bariatric surgery (RYGB or SG)
  • Speak and read the Dutch language

Exclusion Criteria:

  • Revisional bariatric surgery (e.g. sleeve conversion, RYGB after gastric banding)
  • Same-day discharge after bariatric surgery
  • Diagnosed OSA with treatment (CPAP, oral appliances)
  • Professional drivers
  • Use of alpha blockers
  • Unable to speak or read the Dutch language

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Without preventive oxygen therapy
Participants will not receive preventive oxygen 2L during the first postoperative night after bariatric surgery.
Active Comparator: With preventive oxygentherapy
Participants will receive preventive oxygen 2L during the first postoperative night after bariatric surgery, standard care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Apnea-Hypopnea Index (AHI)
Time Frame: First postoperative night
AHI will be measured by a home sleep study device (Watchpat300) and will be compared between both arms, the higher the AHI the more severe the sleep apnea
First postoperative night

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complication rate
Time Frame: Until 30 days after surgery
All complication will be scored and will be compared between both arms
Until 30 days after surgery
The number of nursing interventions
Time Frame: First postoperative night
Nursing interventions will be scored on a form and the number of nursing interventions will be compared between both arms
First postoperative night
Type of nursing interventions
Time Frame: First postoperative night
e.g. waking up the patient or starting or increasing oxygen therapy/flow, this will be compared between both arms.
First postoperative night
Oxygen Desaturation Index (ODI)
Time Frame: First postoperative night
ODI will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
AHI during Rapid Eye Movement (REM) sleep
Time Frame: First postoperative night
AHI during REM sleep will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Respiratory disturbance index (RDI)
Time Frame: First postoperative night
RDI will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Mean saturation
Time Frame: First postoperative night
Mean saturation will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Mean saturation during desaturations,
Time Frame: First postoperative night
Mean saturation during desaturations will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Number of desaturations
Time Frame: First postoperative night
Number of desaturations will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Percentage of saturation <90%
Time Frame: First postoperative night
will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Percentage of saturation <88%
Time Frame: First postoperative night
will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Percentage of saturation <85%
Time Frame: First postoperative night
will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Percentage of saturation <80%
Time Frame: First postoperative night
will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Percentage of saturation <70%
Time Frame: First postoperative night
will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Time (minutes) of saturation <90%
Time Frame: First postoperative night
will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Time (minutes) of saturation <88%
Time Frame: First postoperative night
will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Time (minutes) of saturation <85%
Time Frame: First postoperative night
will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Time (minutes) of saturation <80%
Time Frame: First postoperative night
will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Time (minutes) of saturation <70%
Time Frame: First postoperative night
will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Total sleep time (minutes)
Time Frame: First postoperative night
Total sleep time will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Percentage of REM sleep in total sleep time
Time Frame: First postoperative night
Percentage of REM sleep will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Percentage of Deep sleep in total sleep time
Time Frame: First postoperative night
Percentage of Deep sleep will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Percentage of light sleep in total sleep time
Time Frame: First postoperative night
Percentage of light sleep will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night
Percentage of awake time
Time Frame: First postoperative night
Percentage of awake time will be measured by a home sleep study device (Watchpat300) and will be compared between both arms
First postoperative night

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eric Hazebroek, Prof.dr., Rijnstate Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 9, 2024

Primary Completion (Actual)

March 21, 2025

Study Completion (Actual)

March 21, 2025

Study Registration Dates

First Submitted

April 3, 2024

First Submitted That Met QC Criteria

May 22, 2024

First Posted (Actual)

May 29, 2024

Study Record Updates

Last Update Posted (Actual)

July 18, 2025

Last Update Submitted That Met QC Criteria

July 17, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on No preventive oxygen therapy (2L)

Subscribe